Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Gainers

• Tricida, Inc. (NASDAQ:TCDA) rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday.
• Huadi International Group Co., Ltd. (NASDAQ:HUDI) rose 26.7% to $7.16 in pre-market trading after gaining over 3% on Wednesday.
• Starbox Group Holdings Ltd. (NASDAQ:STBX) shares rose 22.1% to $3.65 in pre-market trading after the company reported a rise in FY22 earnings.
• AIM ImmunoTech Inc. (NYSE:AIM) shares rose 15.8% to $0.73 in pre-market trading after dropping 18% on Wednesday. AIM ImmunoTech recently entered into a sponsored collaborative clinical research agreement with Erasmus MC and AstraZeneca.
• Zymeworks Inc. (NASDAQ:ZYME) rose 12% to $11.20 in pre-market trading.
• Berkshire Grey, Inc. (NASDAQ:BGRY) shares rose 11.3% to $0.97 in pre-market trading after dropping 14% on Wednesday.
• TransCode Therapeutics, Inc. (NASDAQ:RNAZ) rose 11% to $0.7680 in pre-market trading after jumping 15% on Wednesday. TransCode Therapeutics recently announced it received written authorization from the FDA that it may proceed with its First-in-Human Phase 0 clinical trial.
• BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) rose 9.1% to $3.02 in pre-market trading after dropping 10% on Wednesday. BiondVax recently announced additional results from preclinical study showing SARS-COV-2 presence of in hamsters treated with BiondVax's NanoAb was below detectable levels.
• CureVac N.V. (NASDAQ:CVAC) rose 8.4% to $10.28 in pre-market trading. UBS upgraded CureVac from Neutral to Buy and announced an $18 price target.
• Humanigen, Inc. (NASDAQ:HGEN) rose 6.5% to $0.1683 in pre-market trading after dropping around 5% on Wednesday.

Losers

• Ontrak, Inc. (NASDAQ:OTRK) fell 12.8% to $0.9762 in pre-market trading. Ontrak shares jumped 95% on Wednesday after the company announced new data showing a reduction in depression and anxiety symptoms for Ontrak Health's Wholehealth+ program members.
• Sigilon Therapeutics, Inc. (NASDAQ:SGTX) shares fell 14.2% to $0.4712 in pre-market trading. Sigilon Therapeutics shares jumped 33% on Wednesday after Canaccord Genuity initiated coverage on the stock with a Buy rating and a $6 price target.
• Olink Holding AB (NASDAQ:OLK) shares fell 11.3% to $21.34 in pre-market trading after the company announced pricing of public offering of 5,831,028 American Depositary Shares at a price of $20 per ADS.
• Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) fell 10% to $18.55 in pre-market trading after the company reported a $125 million proposed public offering of common stock.
• TC Biopharm (Holdings) Plc (NASDAQ:TCBP) fell 9.5% to $5.70 in pre-market trading after gaining around 28% on Wednesday. TC BioPharm recently announced a strategic collaboration to advance gamma-delta T cells in oncology.
• Magic Empire Global Limited (NASDAQ:MEGL) fell 9.2% to $2.75 in pre-market trading after jumping 44% on Wednesday.
• ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) shares fell 8.2% to $2.36 in pre-market trading after dropping over 15% on Wednesday.
• Veris Residential, Inc. (NYSE:VRE) fell 8.1% to $14.95 in pre-market after the company outlined path to unlocking shareholder value.
• Vapotherm, Inc. (NYSE:VAPO) shares dropped 7.1% to $1.45 in pre-market trading after dropping 14% on Wednesday.
• Alcoa Corporation (NYSE:AA) fell 6.5% to $49.96 in pre-market trading after the company reported quarterly results and issued weak guidance.